Overview
| MDL | MFCD25372028 |
|---|
| Molecular Weight | 607.69 |
|---|
| Molecular Formula | C32H32F3N5O2S |
|---|
| SMILES | CC1=C(NC(C2=CC(C3=CC=CS3)=CN=C2)=O)C=C(C(NC4=CC=C(CN5CCN(CC)CC5)C(C(F)(F)F)=C4)=O)C=C1 |
|---|
For research use only.
Storage
3 years,-20°C,powder
1 years,-80°C,in solvent
Shipping
Room temperature shipping(Stability testing shows this product can be shipped without any cooling measures.)
Preparing Stock Solutions
| 1 mg | 5 mg | 10 mg |
| 1 mM | 1.6456 mL | 8.2279 mL | 16.4558 mL |
| 5 mM | 0.3291 mL | 1.6456 mL | 3.2912 mL |
| 10 mM | 0.1646 mL | 0.8228 mL | 1.6456 mL |
| 50 mM | 0.0329 mL | 0.1646 mL | 0.3291 mL |
Description
ALW II-41-27 (compound 7) is a potent inhibitor of with Kd of 12 nM for EphA2.
Targets
EphA2 [1] (Cell-free assay) |
| 12 nM(Kd) |
In vitro
After ALW-II-41-27 (EPHA2 inhibitor) treatment (0.5 μM) in GM for 12 h, the phosphorylation of EPHA2 is decreased (P < 0.05).